S&P 500   5,091.16 (+0.05%)
DOW   39,232.19 (+0.26%)
QQQ   437.45 (+0.15%)
AAPL   181.98 (-0.30%)
MSFT   410.94 (+0.15%)
META   482.08 (-0.40%)
GOOGL   140.78 (-2.21%)
AMZN   175.25 (+0.15%)
TSLA   194.91 (+1.53%)
NVDA   802.47 (+1.81%)
NIO   5.66 (+4.81%)
AMD   178.11 (+0.90%)
BABA   76.20 (+0.32%)
T   16.79 (-0.06%)
F   12.14 (+0.00%)
MU   90.28 (+4.98%)
CGC   3.42 (+1.79%)
GE   154.13 (+0.52%)
DIS   107.90 (+0.15%)
AMC   4.48 (+0.90%)
PFE   27.46 (-1.08%)
PYPL   59.06 (-0.17%)
XOM   103.57 (-0.26%)
S&P 500   5,091.16 (+0.05%)
DOW   39,232.19 (+0.26%)
QQQ   437.45 (+0.15%)
AAPL   181.98 (-0.30%)
MSFT   410.94 (+0.15%)
META   482.08 (-0.40%)
GOOGL   140.78 (-2.21%)
AMZN   175.25 (+0.15%)
TSLA   194.91 (+1.53%)
NVDA   802.47 (+1.81%)
NIO   5.66 (+4.81%)
AMD   178.11 (+0.90%)
BABA   76.20 (+0.32%)
T   16.79 (-0.06%)
F   12.14 (+0.00%)
MU   90.28 (+4.98%)
CGC   3.42 (+1.79%)
GE   154.13 (+0.52%)
DIS   107.90 (+0.15%)
AMC   4.48 (+0.90%)
PFE   27.46 (-1.08%)
PYPL   59.06 (-0.17%)
XOM   103.57 (-0.26%)
S&P 500   5,091.16 (+0.05%)
DOW   39,232.19 (+0.26%)
QQQ   437.45 (+0.15%)
AAPL   181.98 (-0.30%)
MSFT   410.94 (+0.15%)
META   482.08 (-0.40%)
GOOGL   140.78 (-2.21%)
AMZN   175.25 (+0.15%)
TSLA   194.91 (+1.53%)
NVDA   802.47 (+1.81%)
NIO   5.66 (+4.81%)
AMD   178.11 (+0.90%)
BABA   76.20 (+0.32%)
T   16.79 (-0.06%)
F   12.14 (+0.00%)
MU   90.28 (+4.98%)
CGC   3.42 (+1.79%)
GE   154.13 (+0.52%)
DIS   107.90 (+0.15%)
AMC   4.48 (+0.90%)
PFE   27.46 (-1.08%)
PYPL   59.06 (-0.17%)
XOM   103.57 (-0.26%)
S&P 500   5,091.16 (+0.05%)
DOW   39,232.19 (+0.26%)
QQQ   437.45 (+0.15%)
AAPL   181.98 (-0.30%)
MSFT   410.94 (+0.15%)
META   482.08 (-0.40%)
GOOGL   140.78 (-2.21%)
AMZN   175.25 (+0.15%)
TSLA   194.91 (+1.53%)
NVDA   802.47 (+1.81%)
NIO   5.66 (+4.81%)
AMD   178.11 (+0.90%)
BABA   76.20 (+0.32%)
T   16.79 (-0.06%)
F   12.14 (+0.00%)
MU   90.28 (+4.98%)
CGC   3.42 (+1.79%)
GE   154.13 (+0.52%)
DIS   107.90 (+0.15%)
AMC   4.48 (+0.90%)
PFE   27.46 (-1.08%)
PYPL   59.06 (-0.17%)
XOM   103.57 (-0.26%)
NASDAQ:VREX

Varex Imaging (VREX) Stock Price, News & Analysis

$17.03
-0.18 (-1.05%)
(As of 09:36 AM ET)
Today's Range
$17.03
$17.20
50-Day Range
$16.78
$20.72
52-Week Range
$16.72
$23.90
Volume
6,277 shs
Average Volume
320,354 shs
Market Capitalization
$691.42 million
P/E Ratio
17.74
Dividend Yield
N/A
Price Target
$27.00

Varex Imaging MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
56.9% Upside
$27.00 Price Target
Short Interest
Bearish
10.88% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.14
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
11.11%
From $0.99 to $1.10 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.59 out of 5 stars

Medical Sector

273rd out of 935 stocks

Electronic Components, Not Elsewhere Classified Industry

3rd out of 6 stocks


VREX stock logo

About Varex Imaging Stock (NASDAQ:VREX)

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was incorporated in 2016 and is headquartered in Salt Lake City, Utah.

VREX Stock Price History

VREX Stock News Headlines

Varex Imaging Corp.
Varex Shareholders Approve Governance and Incentives
Blue Chips And Billionaires Quietly Investing In "The New Oil"
They're as essential to the tech and AI revolutions as oil was to the industrial revolution. Known as rare earth elements or REEs, these relatively unheard of commodities are essential to semiconductor chips, renewable energy, electric vehicles, and more.
Q1 2024 Varex Imaging Corp Earnings Call
Blue Chips And Billionaires Quietly Investing In "The New Oil"
They're as essential to the tech and AI revolutions as oil was to the industrial revolution. Known as rare earth elements or REEs, these relatively unheard of commodities are essential to semiconductor chips, renewable energy, electric vehicles, and more.
Recap: Varex Imaging Q1 Earnings
VAREX IMAGING (VREX) Lags Q1 Earnings Estimates
Varex to Participate in Two Investor Conferences
Q4 2023 Varex Imaging Corp Earnings Call
Varex Imaging: Q4 Earnings Insights
See More Headlines
Receive VREX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Varex Imaging and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/06/2024
Today
2/25/2024
Next Earnings (Estimated)
5/07/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electronic components, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:VREX
Fax
N/A
Employees
2,400
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$27.00
High Stock Price Target
$30.00
Low Stock Price Target
$24.00
Potential Upside/Downside
+56.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$48.20 million
Pretax Margin
2.88%

Debt

Sales & Book Value

Annual Sales
$893.40 million
Cash Flow
$2.47 per share
Book Value
$14.36 per share

Miscellaneous

Free Float
38,489,000
Market Cap
$698.73 million
Optionable
Optionable
Beta
0.73
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Sunny S. SanyalMr. Sunny S. Sanyal (Age 60)
    President, CEO & Director
    Comp: $1.27M
  • Mr. Shubham Maheshwari (Age 53)
    CFO & Principal Accounting Officer
    Comp: $729.74k
  • Ms. Kimberley E. Honeysett (Age 54)
    Chief Legal Officer, General Counsel & Corporate Secretary
    Comp: $543.81k
  • Mr. Mark S. Jonaitis (Age 62)
    Senior VP & GM of X-Ray Sources
    Comp: $532.89k
  • Mr. Andrew J. Hartmann (Age 61)
    Senior VP & GM of X-ray Detectors
    Comp: $547.61k
  • Mr. Christopher John Belfiore
    Director of Investor Relations
  • David Carmona
    Vice President of Medical Global Sales & Marketing
  • Karen Aranki
    Chief Human Resources Officer
  • Mr. Shaohua Liang
    VP & MD for China














VREX Stock Analysis - Frequently Asked Questions

Should I buy or sell Varex Imaging stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Varex Imaging in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" VREX shares.
View VREX analyst ratings
or view top-rated stocks.

What is Varex Imaging's stock price target for 2024?

1 equities research analysts have issued twelve-month target prices for Varex Imaging's shares. Their VREX share price targets range from $24.00 to $30.00. On average, they expect the company's share price to reach $27.00 in the next year. This suggests a possible upside of 56.9% from the stock's current price.
View analysts price targets for VREX
or view top-rated stocks among Wall Street analysts.

How have VREX shares performed in 2024?

Varex Imaging's stock was trading at $20.50 at the beginning of the year. Since then, VREX stock has decreased by 16.0% and is now trading at $17.21.
View the best growth stocks for 2024 here
.

When is Varex Imaging's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our VREX earnings forecast
.

How were Varex Imaging's earnings last quarter?

Varex Imaging Co. (NASDAQ:VREX) issued its quarterly earnings results on Tuesday, February, 6th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by $0.05. The business earned $190 million during the quarter, compared to the consensus estimate of $187.97 million. Varex Imaging had a trailing twelve-month return on equity of 9.21% and a net margin of 5.08%. Varex Imaging's revenue for the quarter was down 7.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.08 EPS.

What ETFs hold Varex Imaging's stock?

ETFs with the largest weight of Varex Imaging (NASDAQ:VREX) stock in their portfolio include SPDR Kensho Future Security ETF (FITE) and Invesco S&P SmallCap Health Care ETF (PSCH).iShares U.S. Medical Devices ETF (IHI).

What guidance has Varex Imaging issued on next quarter's earnings?

Varex Imaging updated its second quarter 2024 earnings guidance on Tuesday, February, 6th. The company provided earnings per share (EPS) guidance of 0.100-0.300 for the period, compared to the consensus EPS estimate of 0.210. The company issued revenue guidance of $195.0 million-$215.0 million, compared to the consensus revenue estimate of $206.9 million.

What other stocks do shareholders of Varex Imaging own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Varex Imaging investors own include Gilead Sciences (GILD), Pfizer (PFE), Varian Medical Systems (VAR), Verizon Communications (VZ), NVIDIA (NVDA), AT&T (T), AbbVie (ABBV), Bausch Health Companies (BHC), Bank of America (BAC) and International Business Machines (IBM).

Who are Varex Imaging's major shareholders?

Varex Imaging's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.29%), Allspring Global Investments Holdings LLC (7.48%), Dimensional Fund Advisors LP (6.22%), Cooke & Bieler LP (6.00%), Frontier Capital Management Co. LLC (4.45%) and Pzena Investment Management LLC (2.65%). Insiders that own company stock include Jay K Kunkel, Kimberley E Honeysett, Ruediger Naumann-Etienne and Sunny Sanyal.
View institutional ownership trends
.

How do I buy shares of Varex Imaging?

Shares of VREX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:VREX) was last updated on 2/26/2024 by MarketBeat.com Staff